Bridging the Gap in Crisis Care: How Remian Diagnostics Is Advancing Cardiometabolic Disease Care in Humanitarian Settings

When humanitarian crises strike, the immediate focus is often on trauma care, infectious disease outbreaks, food security, and access to clean water. Yet behind these urgent priorities, another silent emergency continues to grow — the disruption of care for millions of displaced people living with chronic conditions such as diabetes, hypertension, and cardiovascular disease.

Sustaining cardiometabolic disease (CMD) care in fragile and conflict-affected settings remains one of the most pressing challenges in global health today. Managing chronic illness requires continuity: regular screening, monitoring, diagnostics, medication access, and follow-up care. In humanitarian environments where health infrastructure is often damaged or overwhelmed, maintaining this continuity becomes extremely difficult.

This challenge was the focus of the Knowledge Exchange Convening on Non-Communicable Disease (NCD) Innovations in Humanitarian Settings, hosted in Nairobi on April 30th by the African Population and Health Research Center (APHRC) and Elrha. The convening brought together humanitarian actors, Ministries of Health, researchers, innovators, and global health leaders to launch a new research and implementation framework aimed at strengthening NCD care in crisis settings.

Remian Diagnostics Limited is proud to have been highlighted within this global framework as a high-potential innovation capable of supporting the future of CMD care delivery in fragile environments.

Moving Beyond “High-Tech” Toward “Field-Ready” Innovation

One of the report’s most important findings is that many healthcare innovations fail in humanitarian settings not because the technology itself is ineffective, but because local systems often lack the infrastructure needed to sustain them.

Fragile environments require diagnostic systems that are practical, decentralized, resilient, and easy to operate under difficult conditions. Solutions must continue functioning despite unstable electricity, limited laboratory infrastructure, disrupted supply chains, and shortages of specialized personnel.

The report emphasizes three strategic priorities for healthcare innovation in humanitarian settings:

  • Ensuring continuity of diagnostic and patient monitoring services even when primary healthcare systems are disrupted.
  • Supporting low-tech, community-led healthcare delivery models that can be implemented by frontline health workers with minimal laboratory dependency.
  • Designing adaptable diagnostic tools capable of functioning reliably in harsh and resource-constrained environments.

These priorities align closely with Remian Diagnostics’ mission and operational approach. Our focus has always been on strengthening access to reliable point-of-care diagnostics that support frontline decision-making where healthcare access is most vulnerable.

What This Recognition Means for Remian Diagnostics Limited

Being recognized within this global framework represents more than institutional visibility. It positions Remian Diagnostics Limited as an emerging stakeholder in the future of humanitarian healthcare delivery and reinforces the importance of scalable African-led innovation in global health systems.

As humanitarian health priorities continue to evolve, Remian Diagnostics Limited is strategically positioned to contribute across two critical areas:

Strengthening Frontline Diagnostic Access

We are advancing point-of-care diagnostic solutions that enable rapid and reliable CMD screening and monitoring at the community and primary healthcare level, helping reduce delays in diagnosis and treatment.

Enabling Community-Based Care Models

By reducing dependence on centralized laboratories and complex logistics systems, our solutions support decentralized healthcare delivery models that are scalable, accessible, and sustainable.

A Shared Vision for the Future of Humanitarian Healthcare

The future of humanitarian healthcare will depend on solutions that are not only innovative, but also practical, durable, and deployable in the environments where they are needed most.

As the global burden of non-communicable diseases continues to rise, continuity of chronic disease care can no longer remain secondary during humanitarian response efforts. Diagnostics must become more accessible, adaptable, and community-centered.

Remian Diagnostics remains committed to supporting this transformation by developing resilient diagnostic solutions that strengthen healthcare access for vulnerable populations across Africa and beyond.

We are honored to be recognized alongside leading global health stakeholders working to reimagine how chronic disease care can be sustained in humanitarian settings and look forward to contributing to the next phase of impact-driven innovation in global health.  

Read more : https://www.elrha.org/resource/innovations-for-cardiometabolic-disease-care-in-humanitarian-settings